Currently out of the existing stock ratings of Sahil Kazmi, 6 are a BUY (100%).
Analyst Sahil Kazmi, has had 66.67% of price targets met with an average potential upside of 133.11%, reached in 162 days on average. Previously, Sahil Kazmi worked at B. RILEY.
Sahil Kazmi has documented 12 price targets and ratings displayed on 1 stocks.
Most recent stock forecast was given on HROW, Harrow Health at 04-Dec-2024.
Analyst best performing recommendations are on HROW (HARROW HEALTH).
The best stock recommendation documented was for HROW (HARROW HEALTH) on 11/14/2023. The price target of $30 was fulfilled within 268 days with a profit of $21.79 (265.41%), with a performance score of 9.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Jun-2025
$63
$32.88 (109.16%)
$63
7 days ago
(11-Nov-2026)
0/10 (0%)
$33.63 (114.50%)
Buy Since 15-May-2024
$60
$29.88 (99.20%)
$65
6 months 4 days ago
(14-May-2026)
4/10 (40%)
$29.14 (94.43%)
112
$88
$57.88 (192.16%)
$91
6 months 5 days ago
(13-May-2026)
0/4 (0%)
$58.17 (195.01%)
Buy Since 06-Feb-2025
$70
$39.88 (132.40%)
$70
7 months 30 days ago
(19-Mar-2026)
0/10 (0%)
$35.59 (103.43%)
Buy Since 10-Dec-2018
$60
$29.88 (99.20%)
$70
8 months 14 days ago
(04-Mar-2026)
7/9 (77.78%)
$20.78 (52.98%)
324